Follow the Parnax Lab share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €1.6bn. The latest transaction was filed on 6 August 2026 (Acquisition). Among the most active insiders: Prakash Mahasukhlal Shah. Every trade is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 11,597 of 28,064 companies
56.3
score / 100
Value
58
Quality
55
FCF yld-6.0%
Earn yld7.6%
EV/EBITDA8.0x
ROE13%
Gross mgn41%
Net mgn4.7%
Debt/EBITDA2.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Parnax Lab is a company listed on the XBOM, specializing in the development of innovative solutions in the laboratory sector. It focuses on the research and production of chemical and biological products.